About Jill DeSimone
Form D filings for Affini-T Therapeutics in 2024 list Jill DeSimone as director.
Jill DeSimone first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Jill DeSimone in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Jill DeSimone works with at each company, as listed on that company's latest Form D.
Affini-T Therapeutics, Inc. · Form D, Oct 15, 2024
LI
Lucio Iannone
Director
KB
Kathy Bergsteinsson
Executive officer
DF
Daniel Faga
Director
AG
Arjun Goyal
Director
MV
Michael Varney
Director
JK
Joseph Knowles
Chief Executive Officer and director
KY
Kathy Yi
Executive officer